Leslie Trigg - Jun 1, 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
Chair and CEO, Director
Signature
By: John L Brottem For: Leslie Trigg
Stock symbol
OM
Transactions as of
Jun 1, 2022
Transactions value $
-$512,001
Form type
4
Date filed
6/2/2022, 04:30 PM
Previous filing
May 17, 2022
Next filing
Aug 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $55.4K +14.3K +4.89% $3.88 306K Jun 1, 2022 Direct
transaction OM Common Stock Sale -$299K -14.3K -4.66% $20.95 292K Jun 1, 2022 Direct F1, F2
transaction OM Common Stock Options Exercise $61K +15.7K +5.38% $3.88 308K Jun 1, 2022 Direct
transaction OM Common Stock Sale -$329K -15.7K -5.1% $20.95 292K Jun 1, 2022 Direct F1, F2
holding OM Common Stock 8.77K Jun 1, 2022 Trigg Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -15.7K -100% $0.00* 0 Jun 1, 2022 Common Stock 15.7K $3.88 Direct F3
transaction OM Performance Options (right to buy) Options Exercise $0 -14.3K -6.98% $0.00 191K Jun 1, 2022 Common Stock 14.3K $3.88 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2,2022.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$21.99 - 17,954 shares; $21.00-$22.99 - 11,446 shares; $23.00-$23.99 - 600 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This option vested in 48 equal monthly installments beginning on October 19, 2017.
F4 In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.